Clearside Biomedical, Inc. Profile Avatar - Palmy Investing

Clearside Biomedical, Inc.

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable susp…

Biotechnology
US, Alpharetta [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Clearside Biomedical, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of CLSD's Analysis
CIK: 1539029 CUSIP: 185063104 ISIN: US1850631045 LEI: - UEI: -
Secondary Listings
CLSD has no secondary listings inside our databases.